BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ndayishimiye J, Popat A, Blaskovich M, Falconer JR. Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides. J Control Release 2020;324:728-49. [PMID: 32380201 DOI: 10.1016/j.jconrel.2020.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Raza A, Ngieng SC, Sime FB, Cabot PJ, Roberts JA, Popat A, Kumeria T, Falconer JR. Oral meropenem for superbugs: challenges and opportunities. Drug Discov Today 2021;26:551-60. [PMID: 33197621 DOI: 10.1016/j.drudis.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lin L, Chi J, Yan Y, Luo R, Feng X, Zheng Y, Xian D, Li X, Quan G, Liu D, Wu C, Lu C, Pan X. Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era. Acta Pharm Sin B 2021;11:2609-44. [PMID: 34589385 DOI: 10.1016/j.apsb.2021.07.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
3 Wang C, Hong T, Cui P, Wang J, Xia J. Antimicrobial peptides towards clinical application: Delivery and formulation. Adv Drug Deliv Rev 2021;175:113818. [PMID: 34090965 DOI: 10.1016/j.addr.2021.05.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
4 Ndayishimiye J, Popat A, Kumeria T, Blaskovich MA, Robert Falconer J. Supercritical carbon dioxide assisted complexation of benznidazole: γ-cyclodextrin for improved dissolution. International Journal of Pharmaceutics 2021;596:120240. [DOI: 10.1016/j.ijpharm.2021.120240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Maghrabia A, Boughdady M, Meshali M. Design and Optimization of New Enteric Nanoparticles of Ceftriaxone for Oral Delivery: In vitro and in vivo Assessments. Int J Nanomedicine 2021;16:5937-53. [PMID: 34511899 DOI: 10.2147/IJN.S319176] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luong HX, Ngan HD, Thi Phuong HB, Quoc TN, Tung TT. Multiple roles of ribosomal antimicrobial peptides in tackling global antimicrobial resistance. R Soc open sci 2022;9:211583. [DOI: 10.1098/rsos.211583] [Reference Citation Analysis]
7 Ndayishimiye J, Kumeria T, Popat A, Blaskovich MA, Falconer JR. Understanding the relationship between solubility and permeability of γ-cyclodextrin-based systems embedded with poorly aqueous soluble benznidazole. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ang CW, Tan L, Qu Z, West NP, Cooper MA, Popat A, Blaskovich MAT. Mesoporous Silica Nanoparticles Improve Oral Delivery of Antitubercular Bicyclic Nitroimidazoles. ACS Biomater Sci Eng 2021. [PMID: 34464089 DOI: 10.1021/acsbiomaterials.1c00807] [Reference Citation Analysis]
9 Flynn J, Ryan A, Hudson SP. Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics. Eur J Pharm Biopharm 2021;165:149-63. [PMID: 34020021 DOI: 10.1016/j.ejpb.2021.05.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ndayishimiye J, Cao Y, Kumeria T, Blaskovich MAT, Falconer JR, Popat A. Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin. J Mater Chem B 2021;9:7145-66. [PMID: 34525166 DOI: 10.1039/d1tb01430g] [Reference Citation Analysis]
11 Huang W, Meng L, Chen Y, Dong Z, Peng Q. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy. Acta Biomater 2022;140:102-15. [PMID: 34896632 DOI: 10.1016/j.actbio.2021.12.005] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Raza A, Sime FB, Cabot PJ, Roberts JA, Falconer JR, Kumeria T, Popat A. Liquid CO 2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem. ACS Biomater Sci Eng 2021;7:1836-53. [DOI: 10.1021/acsbiomaterials.0c01284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kokulnathan T, Chen T, Chen S, Ahmed F, Hasan P, Bilgrami A, Kumar S. A robust combination of dysprosium vanadate/halloysite nanotubes: the electrochemical system for dimetridazole detection. Materials Today Chemistry 2022;24:100890. [DOI: 10.1016/j.mtchem.2022.100890] [Reference Citation Analysis]
14 Tran PHL, Lee BJ, Tran TTD. Current developments in the oral drug delivery of fucoidan. Int J Pharm 2021;598:120371. [PMID: 33581274 DOI: 10.1016/j.ijpharm.2021.120371] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Parekh K, Mehta TA, Dhas N, Kumar P, Popat A. Emerging Nanomedicines for the Treatment of Atopic Dermatitis. AAPS PharmSciTech 2021;22:55. [PMID: 33486609 DOI: 10.1208/s12249-021-01920-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Luo G, Zhang J, Sun Y, Wang Y, Wang H, Cheng B, Shu Q, Fang X. Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis. Nanomicro Lett 2021;13:88. [PMID: 34138348 DOI: 10.1007/s40820-021-00598-3] [Reference Citation Analysis]